In recent years, the worldwide spread of the so-called high-risk clones of multidrug-resistant
or extensively drug-resistant (MDR/XDR) Pseudomonas aeruginosa has become a public …

The increasing prevalence of chronic and hospital-acquired infections produced by
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …

Carbapenem-resistant Klebsiella pneumoniae (CR-KP) is becoming a common cause of
healthcare-associated infection in Italy, with high morbidity and mortality. Prevalent CR-KP …

Objectives Characterization of the mechanisms driving ceftolozane/tazobactam resistance
development in 5 of 47 (10.6%) patients treated for MDR Pseudomonas aeruginosa …

This study describes the largest clinical experience using ceftolozane/tazobactam (C/T) for
different Pseudomonas aeruginosa infections. A retrospective study was performed at 22 …

Using a large multicenter prospective cohort of Pseudomonas aeruginosa bacteremia, we
demonstrate that the exoU type III secretion system genotype is independently associated …

Diseases caused by antibiotic-resistant bacteria in hospitals are the outcome of complex
relationships between several dynamic factors, including bacterial pathogenicity, the fitness …

This study assessed the molecular epidemiology, resistance mechanisms, and susceptibility
profiles of a collection of 150 extensively drug-resistant (XDR) Pseudomonas aeruginosa …

Pseudomonas aeruginosa is among the leading causes of severe nosocomial infections,
particularly affecting critically ill and immunocompromised patients. Here we review the …

Recent reports have revealed the existence of widespread extensively drug-resistant (XDR)
P. aeruginosa high-risk clones in health care settings, but there is still scarce information on …